1. Efficacy and safety of acoziborole in patients with human African trypanosomiasis caused by Trypanosoma brucei gambiense: a multicentre, open-label, single-arm, phase 2/3 trial. Issue 4 (April 2023) Authors: Betu Kumeso, Victor Kande; Kalonji, Wilfried Mutombo; Rembry, Sandra; Valverde Mordt, Olaf; Ngolo Tete, Digas; Prêtre, Adeline; Delhomme, Sophie; Ilunga Wa Kyhi, Médard; Camara, Mamadou; Catusse, Julie; Schneitter, Stefan; Nusbaumer, Morgane; Mwamba Miaka, Erick; Mahenzi Mbembo, Hélène; Makaya Ma... Journal: Lancet infectious diseases Issue: Volume 23:Issue 4(2023) Page Start: 463 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗